| Literature DB >> 35200671 |
Lucija Perković1, Elvis Djedović1, Tamara Vujović1, Marija Baković1, Tina Paradžik1,2, Rozelindra Čož-Rakovac1,2.
Abstract
The diversity of algal species is a rich source of many different bioactive metabolites. The compounds extracted from algal biomass have various beneficial effects on health. Recently, co-culture systems between microalgae and bacteria have emerged as an interesting solution that can reduce the high contamination risk associated with axenic cultures and, consequently, increase biomass yield and synthesis of active compounds. Probiotic microorganisms also have numerous positive effects on various aspects of health and represent potent co-culture partners. Most studies consider algae as prebiotics that serve as enhancers of probiotics performance. However, the extreme diversity of algal organisms and their ability to produce a plethora of metabolites are leading to new experimental designs in which these organisms are cultivated together to derive maximum benefit from their synergistic interactions. The future success of these studies depends on the precise experimental design of these complex systems. In the last decade, the development of high-throughput approaches has enabled a deeper understanding of global changes in response to interspecies interactions. Several studies have shown that the addition of algae, along with probiotics, can influence the microbiota, and improve gut health and overall yield in fish, shrimp, and mussels aquaculture. In the future, such findings can be further explored and implemented for use as dietary supplements for humans.Entities:
Keywords: algae; bioactive compounds; co-culture; human health; nutraceuticals; probiotics
Mesh:
Year: 2022 PMID: 35200671 PMCID: PMC8880515 DOI: 10.3390/md20020142
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Phylogenetic relationships of microalgal species studied for their use in food or food ingredients. Species designated with red are approved as GRAS (Generally Recognized as Safe) by the FDA. The phylogenetic tree is built using the phyloT tool (https://phylot.biobyte.de/, accessed on 16 January 2022) and is based on NCBI taxonomy. The classification of Shizochytrium sp. as microalga is questionable [40].
Overview of some microalgal species studied for food and food ingredients, and their main bioactive molecules. Species marked in red are approved as GRAS by the FDA.
| Microalgae | Fatty Acids | Pigments | Other | Ref. |
|---|---|---|---|---|
| / | / | Polysaccharides | [ | |
|
| / | / | Mycosporine-like amino acids (MAA) | [ |
|
| / | / | Lyngbic acid, malyngamides, | [ |
|
| Monounsaturated (oleic acid) and polyunsaturated (γ-linolenic acid, DHA) | Zea, Ast, β-Car, Lut, Cantha | / | [ |
|
| Polyunsaturated (γ-linolenic acid) | C-PC, β-Car | α-tocopherol | [ |
|
| / | C-PC, β-Car | α-tocopherol, α-lipoic acid | [ |
|
| Saturated (palmitic acid), | β-Car, Chl | / | [ |
|
| Polyunsaturated (EPA and DHA) | β-Car, Zea, Diato, Diadino, Neo | Paramylon, | [ |
|
| Polyunsaturated (EPA and DHA) | Fuco, Chl | Amino acids (Arg, Met, Lys, | [ |
|
| Saturated (myristic and palmitic acid), | Fuco, Lut, Zea, β-Car, Chl | α-tocopherol, p-sitosterol, stigmasterol | [ |
|
| Polyunsaturated (DHA) | / | / | [ |
| Polyunsaturated (DHA) | Ast, Cantha, β-Car, Ech | / | [ | |
|
| Polyunsaturated (EPA) | Ast, Cantha, Chl | / | [ |
|
| Polyunsaturated (EPA) | / | α-tocopherol | [ |
|
| Polyunsaturated (EPA) | Chl | / | [ |
|
| Polyunsaturated (EPA) | / | / | [ |
|
| Polyunsaturated (EPA) | Chl | / | [ |
|
| Saturated (palmitic and stearic acid), monounsaturated (oleic acid), and polyunsaturated (linoleic and linolenic acid) | Lut | / | [ |
|
| Saturated (palmitic and stearic acid), monounsaturated (oleic acid), and polyunsaturated (linolenic acid) | Ast, β-Car, Lut, Cantha, Lyco | / | [ |
| Saturated (stearic, palmitic, and lauric acid), monounsaturated (oleic acid), polyunsaturated (linoleic and α-linoleic acid) | Lut, Ast, β-Car, Chl | Haemagglutinin, MAA, amino acids (Ile, Leu, Met, Lys, Ala, Val, Arg, Cys and others), vitamin B, C, E | [ | |
|
| / | Ast | / | [ |
|
| Saturated (palmitic acid), monounsaturated (oleic acid), polyunsaturated (α-linoleic and linoleic acid) | Chl | / | [ |
|
| / | β-Car, α-Car, Zea, Lut | Sterols (7-dehydroporiferasterol, ergosterol) | [ |
MMA—mycosporine-like amino acids; α-Car—α-carotene; β-Car—β-carotene; γ-Car—γ-carotene; Zea—zeaxanthin; Ast—astaxanthin; Lut—lutein; Cantha –canthaxanthin; Fuco—fucoxanthin; Chl a—chlorophyll a; Chl b—chlorophyll b; Chl c—chlorophyll c; Chlide a—chlorophyllide a; Cry—cryptoxanthin; Phe a—pheophytin a; Pheide a—pheophorbide a; PE—phycoerythrin; C-PC—C-phycocyanin; PBPs—phycobiliproteins; Lyco—lycopene; Lo—loroxanthin; Neo—neoxanthin; Ax—antheraxanthin; Viola—violaxanthin; Ech—echinenone; Diato—diatoxanthin; Diadino—diadinoxanthin; DHA—docosahexaenoic acid; EPA—eicosapentaenoic acid; /—no data to our knowledge. * The classification of Shizochytrium sp. as microalga is controversial [40].
An overview of recent studies in the development of microalgae and probiotics co-cultivation. The table shows process parameters and inoculation ratios, as well as the aims of studies from different research studies.
| Microalgae | Probiotic Microorganism | T [°C] | pH | Inoculum Ratio | Agitation | Aim of Study | Ref. |
|---|---|---|---|---|---|---|---|
|
| 22 ± 1 | No data | No data | Manually shaken twice daily | Effect on the growth rate of microalgae | [ | |
|
|
| 4 | No data | 1:1000 | Without | Evaluate microbial effects (antiviral) on rotavirus | [ |
|
| “Probiotic” bacterial strain isolates | 25 | 8.5 | 6:1 | 100 rpm on an orbital shaker | Enhancing eicosapentaenoic acid (EPA) production | [ |
|
| 20 | No data | No data | No data | Enhancing growth rate | [ | |
|
| 28 ± 1 | 8 | 4.5:1 | Air-flow | In vitro growth of co-cultured microalgae and bacteria and their effect on oyster | [ | |
|
|
| 28 | 7.2 | 1:1 | Air-flow (with CO2) and stir bar | Investigation of oxidative stress in microalgae | [ |
|
|
| 37 | 6.8 | / | No data | Stimulation of Lactic Acid bacteria growth with spirulina powder and their antibacterial activity | [ |
|
|
| 37 | No data | No data | Without | Evaluation of solid-state fermentation of | [ |
|
|
| 42 | Endpoint pH = 4.6–4.7 | No data | No data | Formulation of probiotic yogurts enriched with Spirulina biomass | [ |
|
| 37 | No data | / | No data | Prebiotic effect of algal extracts on growth of probiotic species | [ |
Figure 2A contractive overview of the methods used for studies of microalgae and probiotic consortia. Co-cultivation begins with inoculation of microalgae and bacteria. Either viable microalga or its powder/extract can serve as an inoculum. The system in which the microbes are inoculated can be closed or open system (flow-through ponds; tubular photobioreactors); Petri dishes/biofilms in incubators; orbital shakers; or flasks with air/CO2 supply. During cultivation, growth parameters are usually measured by cell counting (CFU; hematocytometer) and optical density. Downstream processing is performed by separating biomass and supernatant, which are subjected to analytical analysis.
Figure 3An overview of the implementation of microalgae and probiotic bacteria in co-culture systems. Dry microalgal powder combined with probiotic bacteria finds its application in various food additives approved for human consumption. Its synergistic action has been shown to improve the qualitative composition and sensory properties of various dairy products. It also has an inhibitory effect on viruses or bacteria that disturb the balance of the human intestinal microbiota and can potentially contribute to the bone health. Food preparations consisting of viable cells of microalgae in co-culture with probiotic bacteria are already finding application in sustainable aquaculture.